Core Laboratories Inc. (CLB) P/E ratio

P/E ratio today
24.7×

Core Laboratories Inc. (CLB) trades at 24.7× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 23.6×. That is 10.1% lower than the 26.2× of fiscal 2024. Figures as of 18 Nov 2026, 06:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
24.7×
P/E ratio, fiscal 2025
23.6×
Change on fiscal 2024
−10.1%
Highest on record
53.1×fiscal 2021
Lowest on record
20.5×fiscal 2023
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Core Laboratories Inc. P/E ratio, in more detail

Today's figure is 4.7% above the fiscal 2025 year-end.

Across the 5 fiscal year-ends on record (2021–2025), the highest was 53.1× in fiscal 2021 and the lowest 20.5× in fiscal 2023. Today's P/E ratio is higher than at 40% of the 5 fiscal year-ends on record; their median is 26.2×.

History · 5 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Core Laboratories Inc. P/E ratio, year by year

Core Laboratories Inc. (CLB) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today24.7×—$8.39—
202523.6× 10.1% down$16.03$0.68
202426.2× 27.7% up$17.31$0.66
202320.5× 57.7% down$17.66$0.86
202248.6× 8.5% down$20.27$0.42
202153.1×—$22.31$0.42

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

More on CLB

Core Laboratories Inc., figure by figure

Core Laboratories Inc. (CLB) overview: price, valuation and scorecard

Core Laboratories Inc. P/E ratio: questions and answers

What is Core Laboratories Inc.'s P/E ratio?

Core Laboratories Inc. (CLB) trades at 24.7× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 23.6×. That is 10.1% lower than the 26.2× of fiscal 2024.

Is Core Laboratories Inc.'s P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 40% of the 5 fiscal year-ends on record; their median is 26.2×.

What are the highest and lowest P/E ratio figures on record for Core Laboratories Inc.?

Across the 5 fiscal year-ends on record (2021–2025), the highest was 53.1× in fiscal 2021 and the lowest 20.5× in fiscal 2023.

How is Core Laboratories Inc.'s P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Core Laboratories Inc. (CLB) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/CLB/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.